Evidence map›Paper›PMID 30683112›Full record

ArticleBiomedical engineering online2019

Potential biomarkers of acute myocardial infarction based on weighted gene co-expression network analysis.

Zhihua Liu, Chenguang Ma, Junhua Gu, Ming Yu

Abstract read
In one paragraph

Article in Biomedical engineering online, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Study on the interaction mechanism betweenAnnals of translational medicine · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhihua LiuShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. zh.liu@siat.ac.cn.
Chenguang MaTsinghua University, Beijing, 100084, China.
Junhua GuShenzhen Yuqiu Biological Big Data Research Institute, Shenzhen, 518033, China.
Ming YuShenzhen Yuqiu Biological Big Data Research Institute, Shenzhen, 518033, China.

Funding

SZ Basic Research Grant JCYJ20150401145529007SZ Technology Research Grant CXZZ20151015163619907SZ Technology Research Grant JSGG20160229123927512SZ Technology Research Grant KQJSCX20170331161941176
6 · The paper itself

Abstract

backgroundAcute myocardial infarction (AMI) is the common cause of mortality in developed countries. The feasibility of whole-genome gene expression analysis to identify outcome-related genes and dysregulated pathways remains unknown. Molecular marker such as BNP, CRP and other serum inflammatory markers have got the notice at this point. However, these biomarkers exhibit elevated levels in patients with thyroid disease, renal failure and congestive heart failure. In this study, three groups of microarray data sets (GES66360, GSE48060, GSE29532) were collected from GEO, a total of 99, 52 and 55 samples, respectively. Weighted gene co-expression network analysis (WGCNA) was performed to obtain a classifier which composed of related genes that best characterize the AMI.

resultsHere, this study obtained three groups of microarray data sets (GES66360, GSE48060, GSE29532) on AMI blood samples, a total of 99, 52 and 24 samples, respectively. In all, 4672 genes, 3185 genes, 3660 genes were identified in GSE66360, GSE48060, GSE60993 modules, respectively. We preformed WGCNA, GO and KEGG pathway enrichment analysis on these three data sets, finding function enrichment of the differential expression gene on inflammation and immune response. Transcriptome analysis were performed in AMI patients at four time points compared to CAD patients with no history of MI, to determine gene expression profiles and their possible changes during the recovery from myocardial infarction.

conclusionsThe results suggested that three overlapping genes (FGFBP2, GFOD1 and MLC1) between two modules could be a potential use of gene biomarkers for the diagnose of AMI.

Indexed as

Gene Expression ProfilingAcute Coronary SyndromeBiomarkersBlood ProteinsCase-Control StudiesCluster AnalysisComputational BiologyDiabetes Mellitus, Type 1Gene Expression RegulationHumansInflammationMembrane ProteinsMyocardial InfarctionOligonucleotide Array Sequence AnalysisOxidoreductasesPatient DischargeBiomarkersBlood ProteinsFGFBP2 protein, humanGFOD1 protein, humanMembrane ProteinsMLC1 protein, humanOxidoreductasesAcute myocardial infarctionFunctional enrichment analysisGene ontologyWeighted gene co-expression network analysis

Identifiers

PMID30683112
PMCPMC6347746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.